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1  | INTRODUC TION
Our understanding of skin morphology and lipid composition has 
benefitted greatly from the use of in vivo animal models.[1-3] In 
particular, mouse models have been proven a valuable tool in skin 
research as it offers the possibility to genetically manipulate these 
animals to study the role of specific skin components (eg enzymes, 
proteins, receptors) and to generate in vivo diseased skin models.[1,2] 
In research, the back skin and the ear skin of mice are commonly 
used sites. However, previous studies reported differential effects/
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The skin of the ear and the back are frequently selected sites in skin research using 
mouse models. However, distinct responses to treatment have been described be-
tween these two sites in several studies. Despite the crucial role of the stratum cor-
neum (SC) in the skin barrier function of both dorsal back and ear skin, it remains 
unclear whether differences in lipid composition might underlie altered responses. 
Here, we compared the skin morphology and the barrier lipid composition of the ear 
with the back skin of wild-type mice. The ear contained more corneocyte layers in 
the SC and its barrier lipid composition was enriched with sphingosine ceramide sub-
classes, especially the short ones with a total chain length of 33-34 carbons. The free 
fatty acid (FFA) profile in the ear skin shifted towards shorter chains, significantly 
reducing the mean chain length to 23.3 vs 24.7 carbons in the back skin. In line, FFA 
species in the ear displayed a twofold increase in unsaturation index (P < .001). Gene 
expression in the ear skin revealed low expression of genes involved in lipid synthesis 
and uptake, indicating a reduced metabolic activity. Finally, the effects of hypercho-
lesterolaemia on SC FFA composition was compared in ear and back skin of apolipo-
protein E knockout (APOE−/−) mice. Interestingly, the FFA profile in APOE−/− ear skin 
was minimally affected, while the FFA composition in the back skin was markedly 
changed in response to hypercholesterolaemia. In conclusion, ear and back skin have 
distinct barrier lipids and respond differently to elevated plasma cholesterol.
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phenotypes on ear skin vs the back skin regarding, among others, 
drug treatment (eg imiquimod-induced psoriasis, allergic contact 
dermatitis), melanocyte function and tissue regeneration.[4-6] The 
back skin comprises a relatively large area for performing experi-
ments, but in hairy mice it contains a high density of hair follicles 
(fur) that can complicate the interpretation of the results.[5] In most 
studies, the fur is shaved to allow skin treatment and analysis. At 
the same time, the hair follicles may offer an alternative pathway for 
compound permeation.[7,8] In contrast, the ear represents an easily 
accessible, but small, skin area with a low density of hair follicles and 
centrally supported by a cartilaginous tissue framework.[5]
Regardless of the skin site, the stratum corneum (SC) has a criti-
cal role in skin barrier function protecting against body desiccation 
and harmful chemicals and pathogens.[9] The SC is a well-organized 
structure of corneocytes (dead cornified keratinocytes) surrounded 
by an extracellular lipid matrix with free fatty acids (FFAs), ceramides 
(CERs) and cholesterol as major lipid classes.[10] Currently, however, 
there are no studies comparing SC lipids as the primary barrier com-
ponents in the back vs ear skin. The lipids constituting the SC matrix 
are mostly synthesized by differentiating keratinocytes[10] or taken 
up from the plasma via lipoprotein receptors (eg low-density lipopro-
tein receptor, scavenger receptor class B member I (SR-BI) and clus-
ter of differentiation 36 (CD36)).[11-13] For the skin barrier function, 
the only continuous pathway connecting the environment with the 
viable epidermis is the SC extracellular lipid matrix.[14] Alterations in 
the composition of these lipids have been described in various skin 
pathologies, and it has been demonstrated that the SC lipids are cru-
cial for the primary barrier components in the skin.[15-20] Exogenous 
molecules can penetrate the skin via this SC lipid matrix, particularly 
when the SC lipid profile is modified in response to (environmental) 
stressors and inflammatory processes.
Recently, we showed that increased plasma lipoprotein levels as 
described for apolipoprotein E knockout (APOE−/−) and SR-BI−/− mice 
are associated with an altered lipid profile in the back skin at young 
age, affecting mainly the FFA composition.[21,22] In the severely hy-
percholesterolaemic APOE−/− mice, these epidermal lipids changes 
led to functional differences in transepidermal water loss towards a 
less effective skin barrier. APOE−/− mice and other hypercholestero-
laemic mouse models have recently been used to study the relation 
between psoriasis and the comorbidities dyslipidemia and athero-
sclerosis.[23-25] Differential effects on the aggravation of dyslipidemia 
in APOE−/− mice have been described in response to the induction of 
psoriasis-like skin inflammation by topical application of compounds 
on ear vs back skin, with back skin being more effective.[6,26] As lipids 
play a major role in the skin barrier, it is crucial to know whether there 
are differences in lipid barrier in ear vs back skin of APOE−/− mice.
In this study, we used young adult wild-type (WT) mice to com-
pare the morphology, lipid composition and gene expression between 
dorsal and ear skin. In addition, the epidermal lipid composition of 
the well-established hypercholesterolaemic APOE−/− mice was also 
analysed to assess whether the ear skin develops similar differences 
in lipid matrix composition in response to hypercholesterolaemia as 
previously described for the back skin of these mice.[22]
2  | MATERIAL S AND METHODS
Supplementary Material (Appendix S1) contains detailed informa-
tion regarding the applied materials and methods.
2.1 | Animals and samples
Sixteen- to eighteen-week-old female C57BL/6 WT mice and fe-
male APOE−/− mice (obtained from The Jackson Laboratory and 
bred at the Gorlaeus laboratories) were kept under standard labo-
ratory conditions (20°C and light cycle of 12 hours light/12 hours 
dark) with water and standard low-fat chow diet provided ad li-
bitum (Rat and Mouse No.3 breeding diet). Prior killing, the mice 
were anesthetized with a mixture of xylazine, atropine and keta-
mine (70 mg/kg; 1.8 mg/kg; 350 mg/kg body weight, respectively) 
and perfused with phosphate-buffered saline (PBS; 8.13 g/L 
NaCl, 2.87 g/L Na2HPO4, 0.2 g/L KH2PO4, 0.19 g/L KCl in milliQ 
water; pH 7.4). The ears (WT and APOE−/− mice) and the shaved 
back skin (WT mice) were processed for morphological stainings 
(haematoxylin and eosin, and safranin-O), epidermal lipid com-
position analysis (liquid chromatography/mass spectrometry; 
LC/MS) and gene expression analysis (q-PCR, detailed informa-
tion on primers used is available in Table S3). For sebum lipids 
analysis, hairs were collected from the back skin of both WT and 
APOE−/− mice. The sebum lipid composition was analysed by LC/
MS. Experiments were performed in agreement with National 
guidelines and approved Animal Experiments Ethics Committee 
of Leiden University.
2.2 | Statistical analysis
Data are presented as mean ± SD and statistical significance was cal-
culated using GraphPad Prism 8 (GraphPad Software Inc). P values 
below 0.05 were considered significant.
3  | RESULTS
3.1 | Thicker SC layer in the ear skin compared with 
the back skin
The general morphology of the ear skin and back skin of wild-type 
C57BL/6 mice was assessed by haematoxylin and eosin (HE) and 
safranin-O stainings (Figure 1). HE staining of the ear showed a cen-
tral cartilaginous structure. The hypodermis was more pronounced 
in the back skin than in ear skin. The dermis and epidermis presented 
comparable morphology between the two different skin sites. 
Safranin-O staining revealed a higher number of corneocyte layers 
in the ear SC compared ith the back skin. In the latter, corneocytes 
showed more expansion in response to the alkali environment during 
the safranin-O staining.
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3.2 | Epidermal CER composition strongly differs 
between dorsal and ear skin
For epidermal CER analysis, the epidermis was isolated from der-
mis in the back skin and used for lipid extraction (Figure 2A). For 
the ear skin, lipids were extracted from the most distal section 
of the ear (Figure 2B). Subsequently, the composition of CERs 
in the extracted lipids was analysed by LC/MS. CER subclasses 
nomenclature is a combined representation of the acyl chains 
(non-hydroxy fatty acid [N]; α-hydroxy fatty acid [A] or esterified 
ω-hydroxy fatty acid [EO]) with the sphingoid base (dihydrosphin-
gosine, [dS]; sphingosine [S] or phytosphingosine [P]) as reported 
by Motta et al.[27] The molar percentage distribution of the CER 
subclasses was strikingly different in the ear skin compared with 
the back skin (Figure 2C). The majority of the CERs are sphingo-
sine based (CER[S]) on both skin sites (55% in the back skin vs 75% 
in the ear skin). Nonetheless, in the back skin CER NdS is most 
abundantly present (nearly 40%), while in ear skin NS and AS are 
present at higher concentrations (45% and 28%, respectively) than 
in back skin. The ω-esterified CERs (CER[EO]), composed of CER 
EOS and EOdS, represented 7% of the CERs in the back skin. In the 
ear skin, CER EOS accounted for 14% of the CER content whereas 
CER EOdS was not detected. The CER[non-EO] chain length distri-
bution revealed higher abundance of long-chain CERs (≥43 carbon 
atoms) in the back skin, while ear skin showed increased presence 
of short-chain length CERs (≤42 carbon atoms). Among the short-
chain CERs, the C33 and C34 CERs were strongly present in ear 
skin (22%) compared with back skin (5%) (Figure 2D-E). The mean 
chain length of CER[non-EO] was shorter in the ear (39.5 carbon 
atoms vs. 41.8 carbon atoms in the back skin). When focusing on 
CER [EO], in the back skin, the mean chain length was 67.7 carbons 
while in the ear skin this average was 68.9 carbons (P < .0001) with 
marked detection of CERs with 62-65 carbons, which were merely 
present in the ear skin (Figure 2D-F).
F I G U R E  1   Epidermal and dermal 
morphology of back skin and ear skin. 
Back skin and ear cryostat sections (8 µm) 
stained with (A) haematoxylin and eosin 
(HE, scale bar: 50 µm) and (B) safranin-O 
(scale bar: 20 µm). Micrographs 
representative of 3 WT mice
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F I G U R E  2   CER and FFA composition of the ear and back skin. CERs and FFAs were quantified by LC/MS. Representative images showing 
(A) epidermis isolation from back skin and (B) distal part of the ear (red circled area) used for lipid extraction. CERs are named according 
to nomenclature described by Motta et al (1993); (C) Distribution of CER subclasses (% molar); (D) CER mean chain length; total CER chain 
length distribution (E) CER[non-EO] and (F) CER[EO]; (G) FFA chain length distribution (molar %); (H) mean FFA chain length; (I) molar ratio 
between mono-unsaturated FAs (MUFA) and saturated FAs (SFA). Statistical significance was determined by two-way ANOVA with Holm-
Sǐdak post hoc test and by two-tailed unpaired Student's t test. Data presented as mean ± SD (molar); n = 3-4 samples/group; **P < .01; 
***P < .001; ****P < .0001
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3.3 | Skin lipids in the ear are enriched in short and 
unsaturated FFA species
The composition of the FFAs with a chain length between 20 and 
30 carbons atoms in the ear and the back skin was determined 
by LC/MS. The FFA composition of the ear skin showed a shift 
towards shorter and more unsaturated FFA species (Figure 2G). In 
the back skin, FFA C24:0 and FFA C26:0 were most prevalent FFA, 
accounting for nearly 70% of the total amount of FFAs (Figure 2G). 
In the ear skin, FFA C20:1 and C24:0 were most abundant, com-
prising 43% of the FFAs with a striking fourfold reduction in the 
percentage of FFA C26:0 to only 10% (Figure 2G). These differ-
ences strongly contributed to a shorter mean FFA chain length of 
23.3 carbons in the ear compared with an average FFA chain length 
of 24.5 carbons atoms in the back skin (P < .0001) (Figure 2H). The 
mol ratio between mono-unsaturated FAs (MUFAs) and saturated 
FAs (SFAs) was twofold higher in the ear FFA species (0.36 ± 0.03) 
than in the dorsal FFAs (0.15 ± 0.02) (P < .001) (Figure 2I).
3.4 | Lower basal mRNA levels of genes involved 
lipid synthesis in the ear skin
The expression of genes involved in lipid synthesis and keratino-
cyte proliferation and differentiation was assessed to determine 
the underlying factors responsible for the differences in lipid 
composition in the ear and in the back skin. Basal mRNA levels 
of genes involved in cholesterol synthesis (HMGCS1; twofold), es-
terification (ACAT1; threefold to fourfold) and uptake of lipopro-
teins (LDLR; twofold) were significantly lower in the ear compared 
with the back skin (Figure 3A). In addition, the ear also showed a 
nearly 70% reduction in the expression CERS3 and GBA (synthesis 
of esterified-ω-CERs and cleavage of glucosyl-CERs, respectively) 
with no changes in the expression of DEGS1 (enzyme involved in 
synthesis step of CER[S] from CER[dS]) (Figure 3B). Expression 
of fatty acid synthase (FAS) was reduced by 30% in the ear while 
expression of SCD1, an enzyme involved in fatty acid chain de-
saturation, was comparable between groups (Figure 3C). The ear 
also showed reduced expression of genes involved in FFA chain 
elongation; ELOVL1 (twofold) and ELOVL4 (threefold) (Figure 3C). 
In line with the lower expression of genes related to lipid synthesis, 
mRNA levels of DGAT2 (triglyceride synthesis) and ABCA12 (lipid 
transport to lamellar bodies) were also decreased in the ear skin 
(Figure 3D). The back skin showed higher expression of genes in-
volved in keratinocyte differentiation (IVL) and proliferation (K10) 
markers (P < .0001) (Figure 3D).
3.5 | Changes in plasma lipid composition 
differentially affect dorsal and ear skin
The back skin of hypercholesterolaemic APOE−/− mice shows an al-
tered FFA profile in response to the massively increased levels of 
apolipoprotein B containing lipoprotein particles in the circulation 
at young age.[22] It remains unknown whether the skin in the ears is 
similarly affected by this hypercholesterolaemic profile. Thus, next, 
we analysed the FFA composition in the ear of APOE−/− mice and 
compared it with that described for WT ear skin in Figure 2G. The 
relative distribution of FFA (% total FFA) in the ear of APOE−/− mice 
was nearly comparable to the composition described for WT ear 
(Figure 4A). The FFA composition in the ear of APOE−/− mice showed 
a significant increase in the percentage of FFA C20:0 (P < .0001) ac-
companied by reduction in the percentage of FFA C24:0 (P < .0001). 
Consequently, a small shift towards a shorter chain length was ob-
served in the ear of APOE−/− mice (Figure 4B). The molar ratio be-
tween mono-unsaturated and saturated FFA species was not altered 
(Figure 4C). Sebum lipids, produced by sebaceous glands, contribute 
F I G U R E  3   Ear skin shows lower expression levels of several 
genes involved in skin lipid metabolism and keratinocyte markers. 
mRNA levels of genes related to the synthesis or uptake of (A) 
cholesterol; synthesis of (B) CERs; and (C) FFAs. Expression of 
genes linked to (D) lipid transport in lamellar bodies; triglyceride 
(TG) synthesis; and keratinocyte proliferation and differentiation. 
Statistical significance was determined by two-tailed unpaired 
Student's t test; *P < .05; **P < .01; ****P < .0001. Data presented 
as mean ± SD; n = 5/group
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to the skin surface lipid pool, particularly in back skin with a high den-
sity of hair follicles, and hence, sebaceous glands.[28] Triglycerides, 
a component of sebum lipids, may undergo hydrolysis by microbial 
lipases generating FFAs.[29-31] Thus, next we compared the composi-
tion of the FFAs in the sebum surrounding back skin hairs of both 
WT and APOE−/− mice to assess whether the sebum of APOE−/− mice 
was affected by the hypercholesterolaemic profile of these mice. 
The sebum FFA composition of WT and APOE−/− mice was overall 
comparable (Figure 4D), indicating that the observed differential re-
sponse to hypercholesterolaemia between back and ear skin cannot 
be explained by effects on the FFA content of sebum.
4  | DISCUSSION
In mouse models, both ear and back skin have been proven valu-
able assets in a large range of skin studies.[1-3] However, similari-
ties and differences between ear and back skin are not extensively 
examined. In the present study, we provide evidence that the lipid 
composition of the skin barrier is fundamentally different between 
the two sites, as is the expression of genes related to lipid synthesis 
and keratinocytes differentiation and proliferation. In addition, the 
skin of the ear showed only a minimal response to hypercholester-
olaemic conditions as compared to the back skin.
The density of hair follicles and the number of corneocyte layers 
in the SC are important factors in skin research as they directly re-
late to skin permeability and, thus, barrier function. In hairy mice, the 
high density of hair follicles provides a smaller interfollicular area and 
comprises a permeation pathway into the skin. In the hairy C57Bl6 
mouse strain, melanin production is restricted to the hair follicles 
and absent in the skin. Melanin is mostly produced during the ana-
gen phase of the hair growth, giving the skin a dark pigmentation.[32] 
As hair growth in the murine skin occurs in waves, it leads to the for-
mation of dark pigmented areas (dark patches) and non-pigmented 
areas (“white” patches). The dark skin patches with synchronized hair 
cycles appear after the age of 10 weeks.[32] In this study, “white” skin 
patches at similar position in the back skin were used for analysis as 
different hair cycles can influence the skin response to compounds 
and even the development of inflammation.[25,33] The SC in these 
“white” back skin patches of hairy mice has fewer number of corneo-
cyte layers as compared to ear skin. The back skin of nude mice with 
a larger interfollicular area displays a thicker SC with more corneo-
cyte layers,[34] suggesting that the reduced number of corneocyte 
layers in hairy mice is a direct effect of the presence of dense hair 
follicles and/or fur. The reduced number of corneocyte layers in the 
back skin may require a faster turnover/replacement to preserve the 
barrier, while in the ear skin this turnover may take longer. Also, the 
ear skin has a lower density of blood vessels as well as lymphatic 
F I G U R E  4   FFA composition of the ear and of sebum in normolipidemic WT and hypercholesterolaemic APOE−/− mice. FFA profile: (A) FFA 
chain length distribution profile in the ear skin; (B) molar ratio between mono-unsaturated FFAs (MUFA) and saturated FFAs (SFA) in the ear 
skin; (C) percentage of short chain FFA (FFA chains containing less than 24 carbon atoms) in the ear skin; (D) FFA chain length distribution 
profile in the sebum lipids; (E) molar ratio between mono-unsaturated FFAs (MUFA) and saturated FFAs (SFA) in the sebum lipids; (F) 
percentage of short-chain FFA (FFA chains containing less than 24 carbon atoms) in the sebum lipids. Statistical significance was determined 
by one-way ANOVA with Holm-Sǐdak post hoc test and by two-tailed unpaired Student's t test. Data presented as mean ± SD; n = 3-4 
samples/group; *P < .05; ****P < .0001
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vessels than the back skin indicating a reduced metabolic activity 
and even drainage in the ear.[6,35,36] Accordingly, the basal expression 
of genes related to lipid synthesis/uptake and keratinocyte differ-
entiation and proliferation was significantly higher in the back skin, 
likely reflecting the more active metabolic profile at this site.
The mRNA expression of the enzymes CERS3, ELOVL1 and ELOVL4 
was lower in ear skin as compared to back skin. CERS3 encodes for 
the main ceramide synthase involved in the synthesis of CER[EO], and 
it regulates the elongation of FA chains by ELOVL1 and ELOVL4.[37] 
In vitro co-expression of CERS3 with ELOVL1 leads to an augmented 
production of CERs with a C26:0 acyl chain which is also accompanied 
by an increase in CERs with a C24:0 acyl chain.[37] Further elongation 
of C26:0 FAs is continued by ELOVL4 to generate both CER[non-EO] 
and CER[EO] with acyl chains containing more than 26 carbon 
atoms.[37] In vivo, ELOVL1−/− mice and ELOVL4−/− mice show a remark-
able reduction in CER[EO] content and a shift towards CER containing 
acyl chains shorter than 24 carbons atoms.[37,38] Despite the low levels 
of CERS3 in the ear skin, CER[EO] accounted for a relatively high per-
centage of the CERs in the ear skin, which may be a result of the overall 
percentage distribution of each subclass. Surprisingly, the mean chain 
length of CER[EO] was higher in the ear skin where reduced expres-
sions of ELOVL1 and ELOVL4 were observed. Remarkably, the skin of 
ELOVL4−/− mice also showed major increases in the prevalence of CER 
NS and CER AS, especially containing acyl chain C26:0.[39] In the pres-
ent study, the ear skin showed high prevalence of CER[S], while the 
expression of DEGS1, encoding for the desaturase enzyme that con-
verts CER[dS] into CER[S],[40] was comparable to the back skin, indi-
cating that the absence of ELOVL4 can be related to the accumulation 
of CER NS and CER AS.[39] In line, the reduced expression of CERS3, 
ELOVL1 and ELOVL4 in the ear skin resulted in an increase in the frac-
tion of sphingosine CERs with a total chain length of 33 and 34 carbon 
atoms, especially in CER NS and CER AS subclasses. Although CERs 
are essential components of the skin barrier, little information is avail-
able regarding the mechanism(s) involved in the regulation of ceramide 
synthesis.[41] Other factors, not included in the scope of this study (eg 
acyl-coenzyme A-binding protein), may also impact CER synthesis and 
contribute to the results described here.[41]
The changes in the FFA composition in the ear corroborate with 
the reduced expression of ELOVL1 and ELOVL4 in the ear skin, lead-
ing to a FFA profile enriched with shorter chains. The ear skin also 
showed a higher presence of unsaturated FFA species compared 
with the back skin, although no changes were observed in the basal 
expression of SCD1, an enzyme tightly regulated and subjected to 
fast turn on/off expression.[42,43] Altogether, our LC/MS and PCR 
data show that the skin lipid composition largely varies with the ana-
tomical site even within young adult WT mice. Elucidation of the un-
derlying causes for the reported differences between ear and back 
skin warrants further investigation.
As lipids are important components of the SC, variations in the 
skin lipid composition can affect the barrier function. In atopic der-
matitis patients, the CER profile shows increased levels of CER NS 
and CER AS and a reduction of the average chain length linked to 
increased levels of C34 CERs in these subclasses.[44] These patients 
also have a higher percentage of short and unsaturated FFA species 
in their skin lipids.[44] Human skin equivalents, bioengineered in vitro 
models of human skin often containing activated keratinocytes, also 
show similar changes in lipid profile.[45] In both atopic dermatitis skin 
and in human skin equivalents samples, the altered lipid composition 
results in a reduced barrier function of the skin compared with na-
tive human skin.[44,45] In this view, it is likely that the changes in lipid 
composition described here for the ear skin is not favourable for an 
optimal lipid barrier, which may lead to higher number of corneocyte 
layers in order to compensate for this unfavourable lipid profile.
Lipids provided by plasma lipoproteins are also incorpo-
rated into the skin and hence an imbalance in lipoprotein pro-
file may affect the composition of the barrier lipid pool.[21,22,35,46] 
Hypercholesterolaemic APOE−/− mice develop skin inflammation and 
lipid deposits in the dermal compartment upon ageing and when fed 
a high cholesterol/high fat diet.[47,48] Remarkably, already at young 
age, the back skin of these hypercholesterolaemic mice shows al-
tered epidermal lipid composition prior to the development of 
inflammatory skin profiles.[22] The FFA composition is especially af-
fected in the back skin showing enrichment in short and unsaturated 
chains. In contrast, in the current study we found that the ear skin 
of young APOE−/− mice is minimally affected with only a minor shift 
towards shorter FFA chains. Considering the faster turnover of cor-
neocyte layers in the back skin in combination with higher density of 
lymphatic and blood vessels, this skin site can more readily reflect 
the changes in the plasma lipids. Our findings provide insight why, 
as previously described, the ear and the back skin react differently 
to specific treatments leading to distinct outcomes, for example, 
imiquimod-induced psoriasis.[6]
In conclusion, the morphology and lipid composition of murine 
skin significantly vary depending on the body location, specifically 
in the ear and in the back skin. We suggest that the turnover rate of 
the corneocyte layer in combination with the level of metabolic ac-
tivity of the skin site can be key players in the response to therapeu-
tic intervention and to systemic lipid changes. Nonetheless, defining 
which skin site should be used in studies is not straightforward as the 
skin is a complex organ. It is important to further characterize the 
morphological, inflammatory and metabolic variations among skin 
sites in order to better match the skin site to the goal of the study.
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